Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. [electronic resource]
Producer: 20081217Description: 2055-61 p. digitalISSN:- 1349-7006
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Antisense Elements (Genetics) -- genetics
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- blood supply
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Doxorubicin -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Transfer Techniques
- Genetic Therapy -- methods
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit -- genetics
- Immunohistochemistry
- Ki-67 Antigen -- metabolism
- Liver Neoplasms, Experimental -- blood supply
- Male
- Mice
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Proliferating Cell Nuclear Antigen -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.